Salort-Campana E - Search Results

1

Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy.

Gazzola S, Delmont E, Franques J, Boucraut J, Salort-Campana E, Verschueren A, Sagui E, Hubert AM, Pouget J, Attarian S. Gazzola S, et al. J Neurol Sci. 2017 Jun 15;377:144-148. doi: 10.1016/j.jns.2017.04.015. Epub 2017 Apr 12. J Neurol Sci. 2017. PMID: 28477685

2

[Myasthenia].

Salort-Campana E. Salort-Campana E. Rev Prat. 2023 Mar;73(3):305-306. Rev Prat. 2023. PMID: 37289123 French. No abstract available.

3

[Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].

Aubert S, Salort-Campana E, Franques J, Uzenot D, Pouget J. Aubert S, et al. Rev Neurol (Paris). 2009 Nov;165(11):901-10. doi: 10.1016/j.neurol.2009.01.049. Epub 2009 Mar 26. Rev Neurol (Paris). 2009. PMID: 19327804 French.

4

ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis.

Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J. Gautier G, et al. Amyotroph Lateral Scler. 2010 Aug;11(4):379-82. doi: 10.3109/17482960903426543. Amyotroph Lateral Scler. 2010. PMID: 20001486

5

Response to treatment in patients with Lewis-Sumner syndrome.

Attarian S, Verschueren A, Franques J, Salort-Campana E, Jouve E, Pouget J. Attarian S, et al. Muscle Nerve. 2011 Aug;44(2):179-84. doi: 10.1002/mus.22024. Muscle Nerve. 2011. PMID: 21755505

6

Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.

Attarian S, Salort-Campana E, Nguyen K, Behin A, Andoni Urtizberea J. Attarian S, et al. Rev Neurol (Paris). 2012 Dec;168(12):910-8. doi: 10.1016/j.neurol.2011.11.008. Epub 2012 Apr 30. Rev Neurol (Paris). 2012. PMID: 22551571 Review.

7

Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis.

Fernandez C, Bardin N, De Paula AM, Salort-Campana E, Benyamine A, Franques J, Schleinitz N, Weiller PJ, Pouget J, Pellissier JF, Figarella-Branger D. Fernandez C, et al. Medicine (Baltimore). 2013 Jan;92(1):15-24. doi: 10.1097/MD.0b013e31827ebba1. Medicine (Baltimore). 2013. PMID: 23269233 Free PMC article.

8

[Clinical and molecular diagnosis of facioscapulohumeral dystrophy type 1 (FSHD1) in 2012].

Salort-Campana E, Nguyen K, Lévy N, Pouget J, Attarian S. Salort-Campana E, et al. Rev Neurol (Paris). 2013 Aug-Sep;169(8-9):573-82. doi: 10.1016/j.neurol.2013.07.001. Epub 2013 Sep 4. Rev Neurol (Paris). 2013. PMID: 24011979 French.

9

[Necrotizing myopathies: From genetic to acquired forms].

Salort-Campana E, De Paula AM, Figarella-Branger D, Pouget J. Salort-Campana E, et al. Rev Med Interne. 2014 Jul;35(7):430-6. doi: 10.1016/j.revmed.2013.11.012. Epub 2013 Dec 19. Rev Med Interne. 2014. PMID: 24359726 Review. French.

10

Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers.

Gaillard MC, Roche S, Dion C, Tasmadjian A, Bouget G, Salort-Campana E, Vovan C, Chaix C, Broucqsault N, Morere J, Puppo F, Bartoli M, Levy N, Bernard R, Attarian S, Nguyen K, Magdinier F. Gaillard MC, et al. Neurology. 2014 Aug 19;83(8):733-42. doi: 10.1212/WNL.0000000000000708. Epub 2014 Jul 16. Neurology. 2014. PMID: 25031281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters